Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaji Kumar

Showing results (91-100 of 515) with videos related to

Pageof 52
Sort By:
American Journal of Hematology|March 12, 2021
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significanceJorge J Castillo, Natalie S Callander, Muhamed Baljevic, et al.
Alternative Therapies in Health and Medicine|June 2, 2025
Scope and Role of Integrating Yoga in Homeopathic Medical Education: An Explorative ReviewManoj Ghosh, Neetinakumar J Patil, Kashinath Samagandi, et al.
Leukemia Research|October 6, 2014
Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001Vijay Ramakrishnan, Teresa Kimlinger, Michael Timm, et al.
British Journal of Haematology|February 21, 2020
Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostificationLu Q Wang, Shaji Kumar, George A Calin, et al.
Therapeutic Advances in Hematology|October 7, 2021
Case series: MRD negativity assessment using <sup>11</sup>C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myelomaCheong Ngai, Shaji Kumar, Garrett Chi-Lai Ho, et al.
Cancer Medicine|August 17, 2021
Front-line treatment patterns in multiple myeloma: An analysis of U.S.-based electronic health records from 2011 to 2019Shaji Kumar, Mellissa Williamson, Uzor Ogbu, et al.
Blood|April 26, 2003
Expression of CD52 on plasma cells in plasma cell proliferative disordersShaji Kumar, Teresa K Kimlinger, John A Lust, et al.
Frontiers in Oncology|February 15, 2021
Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCRQiumei Yao, Yinlei Bai, Shaji Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 3, 2020
Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface MarkersRadhika Bansal, Teresa Kimlinger, Kelli Ann Gyotoku, et al.
Haematologica|July 28, 2006
Differential expression of vascular endothelial growth factors and their receptors in multiple myelomaTeresa Kimlinger, Michael Kline, Shaji Kumar, et al.
Pageof 52

Showing results (91-100 of 515) with videos related to

Sort By:
Pageof 52
American Journal of Hematology|March 12, 2021
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significanceJorge J Castillo, Natalie S Callander, Muhamed Baljevic, et al.
Alternative Therapies in Health and Medicine|June 2, 2025
Scope and Role of Integrating Yoga in Homeopathic Medical Education: An Explorative ReviewManoj Ghosh, Neetinakumar J Patil, Kashinath Samagandi, et al.
Leukemia Research|October 6, 2014
Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001Vijay Ramakrishnan, Teresa Kimlinger, Michael Timm, et al.
British Journal of Haematology|February 21, 2020
Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostificationLu Q Wang, Shaji Kumar, George A Calin, et al.
Therapeutic Advances in Hematology|October 7, 2021
Case series: MRD negativity assessment using <sup>11</sup>C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myelomaCheong Ngai, Shaji Kumar, Garrett Chi-Lai Ho, et al.
Cancer Medicine|August 17, 2021
Front-line treatment patterns in multiple myeloma: An analysis of U.S.-based electronic health records from 2011 to 2019Shaji Kumar, Mellissa Williamson, Uzor Ogbu, et al.
Blood|April 26, 2003
Expression of CD52 on plasma cells in plasma cell proliferative disordersShaji Kumar, Teresa K Kimlinger, John A Lust, et al.
Frontiers in Oncology|February 15, 2021
Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCRQiumei Yao, Yinlei Bai, Shaji Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 3, 2020
Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface MarkersRadhika Bansal, Teresa Kimlinger, Kelli Ann Gyotoku, et al.
Haematologica|July 28, 2006
Differential expression of vascular endothelial growth factors and their receptors in multiple myelomaTeresa Kimlinger, Michael Kline, Shaji Kumar, et al.
Pageof 52